Cleveland Biolabs, Inc. (CBLI) Posts In-Line Q1 Loss of 15c/Share

Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q1 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $931 thousand versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on Cleveland Biolabs, Inc. (CBLI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• South Plains Financial Inc. (SPFI) Tops Q2 EPS by 1c
• Netflix, Intuitive Surgical tumble premarket